SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-259621
Filing Date
2020-09-30
Accepted
2020-09-30 16:11:15
Documents
63
Period of Report
2020-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q d21442d10q.htm   iXBRL 10-Q 1052010
2 EX-31.1 d21442dex311.htm EX-31.1 10453
3 EX-31.2 d21442dex312.htm EX-31.2 11085
4 EX-32 d21442dex32.htm EX-32 5125
  Complete submission text file 0001193125-20-259621.txt   5178205

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20200831.xsd EX-101.SCH 34964
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20200831_cal.xml EX-101.CAL 38922
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20200831_def.xml EX-101.DEF 258614
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20200831_lab.xml EX-101.LAB 317585
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20200831_pre.xml EX-101.PRE 294211
10 EXTRACTED XBRL INSTANCE DOCUMENT d21442d10q_htm.xml XML 950692
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 201212381
SIC: 2835 In Vitro & In Vivo Diagnostic Substances